Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808808 · ClinicalTrials.gov registry record
Assessing Choice in the Employer Setting (ACES) Study
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 4,411
- Enrollment target
NCT00808808 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 4,411 participants.
The verdict
NCT00808808 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 4,411 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.
Interventions
- BIOLOGICAL Choice of TIV or FluMist with baseline advertisement
- OTHER Choice of TIV or FluMist with enhanced advertisement and incentives
- BIOLOGICAL Control - Usual care offering TIV only with baseline advertisement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,411 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00808808
The ClinicalTrials.gov registry entry for NCT00808808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Choice of TIV or FluMist with baseline advertisement is the first listed.
NCT00808808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00808808 about?
NCT00808808 is a clinical study titled "Assessing Choice in the Employer Setting (ACES) Study". The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.
What is the current status of trial NCT00808808?
This trial is currently completed. The enrollment target is 4,411 participants. The study started on 2008-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00808808?
The interventions under investigation include: Choice of TIV or FluMist with baseline advertisement (BIOLOGICAL), Choice of TIV or FluMist with enhanced advertisement and incentives (OTHER), Control - Usual care offering TIV only with baseline advertisement (BIOLOGICAL).
Who is sponsoring clinical trial NCT00808808?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.